Structure

Physi-Chem Properties

Molecular Weight:  364.12
Volume:  348.718
LogP:  1.869
LogD:  0.609
LogS:  -2.51
# Rotatable Bonds:  4
TPSA:  141.36
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.611
Synthetic Accessibility Score:  4.304
Fsp3:  0.5
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.821
MDCK Permeability:  1.04605869637453e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.581
Human Intestinal Absorption (HIA):  0.727
20% Bioavailability (F20%):  0.929
30% Bioavailability (F30%):  0.995

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.198
Plasma Protein Binding (PPB):  85.31501007080078%
Volume Distribution (VD):  0.364
Pgp-substrate:  15.80972671508789%

ADMET: Metabolism

CYP1A2-inhibitor:  0.03
CYP1A2-substrate:  0.099
CYP2C19-inhibitor:  0.023
CYP2C19-substrate:  0.087
CYP2C9-inhibitor:  0.019
CYP2C9-substrate:  0.596
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.104
CYP3A4-inhibitor:  0.023
CYP3A4-substrate:  0.14

ADMET: Excretion

Clearance (CL):  2.727
Half-life (T1/2):  0.56

ADMET: Toxicity

hERG Blockers:  0.022
Human Hepatotoxicity (H-HT):  0.234
Drug-inuced Liver Injury (DILI):  0.898
AMES Toxicity:  0.881
Rat Oral Acute Toxicity:  0.138
Maximum Recommended Daily Dose:  0.938
Skin Sensitization:  0.548
Carcinogencity:  0.293
Eye Corrosion:  0.003
Eye Irritation:  0.124
Respiratory Toxicity:  0.931

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC44378

Natural Product ID:  NPC44378
Common Name*:   Frenolicin D
IUPAC Name:   2-[(1R,3S,4aS,10aR)-4a,9,10a-trihydroxy-5,10-dioxo-1-propyl-3,4-dihydro-1H-benzo[g]isochromen-3-yl]acetic acid
Synonyms:  
Standard InCHIKey:  XDYYASNFOIEXFT-KSVPUCKHSA-N
Standard InCHI:  InChI=1S/C18H20O8/c1-2-4-12-18(25)16(23)14-10(5-3-6-11(14)19)15(22)17(18,24)8-9(26-12)7-13(20)21/h3,5-6,9,12,19,24-25H,2,4,7-8H2,1H3,(H,20,21)/t9-,12-,17-,18+/m1/s1
SMILES:  CCC[C@@H]1[C@@]2(C(=O)c3c(cccc3O)C(=O)[C@@]2(C[C@@H](CC(=O)O)O1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2409145
PubChem CID:   72191965
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001640] Naphthopyrans
        • [CHEMONTID:0001641] Naphthopyranones
          • [CHEMONTID:0001646] Naphthopyranone glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33097 Streptomyces sp. RM-4-15 Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[23944931]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 > 80000.0 nM PMID[570793]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC44378 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC280753
0.979 High Similarity NPC94781
0.9586 High Similarity NPC120171
0.9456 High Similarity NPC205918
0.8993 High Similarity NPC470479
0.8986 High Similarity NPC285122
0.898 High Similarity NPC103910
0.8947 High Similarity NPC312482
0.8924 High Similarity NPC471295
0.8917 High Similarity NPC329647
0.8917 High Similarity NPC470735
0.8897 High Similarity NPC114620
0.8897 High Similarity NPC103337
0.8889 High Similarity NPC314257
0.8889 High Similarity NPC3449
0.8859 High Similarity NPC136878
0.8851 High Similarity NPC29932
0.8839 High Similarity NPC314795
0.8831 High Similarity NPC478027
0.8824 High Similarity NPC137301
0.8808 High Similarity NPC474310
0.8792 High Similarity NPC170055
0.8784 High Similarity NPC21873
0.8776 High Similarity NPC257003
0.8774 High Similarity NPC206641
0.8774 High Similarity NPC29552
0.8774 High Similarity NPC472889
0.8774 High Similarity NPC208651
0.8767 High Similarity NPC295339
0.8766 High Similarity NPC472890
0.8758 High Similarity NPC115249
0.8725 High Similarity NPC48130
0.8725 High Similarity NPC300684
0.8725 High Similarity NPC218866
0.8725 High Similarity NPC84568
0.8716 High Similarity NPC474300
0.8701 High Similarity NPC209393
0.8701 High Similarity NPC478231
0.8701 High Similarity NPC474622
0.8701 High Similarity NPC474621
0.8701 High Similarity NPC470408
0.8701 High Similarity NPC205172
0.8701 High Similarity NPC182921
0.8701 High Similarity NPC474824
0.8701 High Similarity NPC218870
0.8699 High Similarity NPC61590
0.8662 High Similarity NPC472055
0.8658 High Similarity NPC476473
0.8654 High Similarity NPC478225
0.8645 High Similarity NPC192219
0.8645 High Similarity NPC82190
0.8645 High Similarity NPC478221
0.8645 High Similarity NPC69043
0.8645 High Similarity NPC174599
0.8645 High Similarity NPC478230
0.8645 High Similarity NPC317585
0.8642 High Similarity NPC294501
0.8639 High Similarity NPC306835
0.8639 High Similarity NPC476477
0.8639 High Similarity NPC299405
0.8639 High Similarity NPC111422
0.8639 High Similarity NPC256463
0.8639 High Similarity NPC216312
0.8639 High Similarity NPC29771
0.8639 High Similarity NPC471602
0.8636 High Similarity NPC478224
0.8636 High Similarity NPC76041
0.8636 High Similarity NPC184284
0.8627 High Similarity NPC475407
0.8627 High Similarity NPC315520
0.8627 High Similarity NPC56204
0.8627 High Similarity NPC472891
0.8618 High Similarity NPC112816
0.8609 High Similarity NPC229264
0.8609 High Similarity NPC120536
0.8599 High Similarity NPC470339
0.859 High Similarity NPC148323
0.859 High Similarity NPC472050
0.859 High Similarity NPC474861
0.859 High Similarity NPC283480
0.8581 High Similarity NPC42262
0.8581 High Similarity NPC315578
0.8581 High Similarity NPC220496
0.8581 High Similarity NPC241349
0.8581 High Similarity NPC37992
0.8581 High Similarity NPC147542
0.8581 High Similarity NPC32749
0.8581 High Similarity NPC327916
0.858 High Similarity NPC478021
0.8571 High Similarity NPC473094
0.8571 High Similarity NPC126739
0.8571 High Similarity NPC173980
0.8571 High Similarity NPC197666
0.8562 High Similarity NPC478020
0.8562 High Similarity NPC478022
0.8562 High Similarity NPC472049
0.8562 High Similarity NPC191930
0.8543 High Similarity NPC474630
0.8542 High Similarity NPC17843
0.8533 High Similarity NPC143898
0.8528 High Similarity NPC183441
0.8528 High Similarity NPC270027
0.8528 High Similarity NPC473113
0.8526 High Similarity NPC266469
0.8526 High Similarity NPC471456
0.8526 High Similarity NPC170189
0.8526 High Similarity NPC208173
0.8523 High Similarity NPC471444
0.8519 High Similarity NPC473096
0.8519 High Similarity NPC473095
0.8516 High Similarity NPC474534
0.8516 High Similarity NPC474533
0.8514 High Similarity NPC26924
0.85 High Similarity NPC249181
0.8493 Intermediate Similarity NPC27407
0.8491 Intermediate Similarity NPC477627
0.8487 Intermediate Similarity NPC63918
0.8477 Intermediate Similarity NPC79627
0.8466 Intermediate Similarity NPC470580
0.8462 Intermediate Similarity NPC281703
0.8462 Intermediate Similarity NPC125487
0.8457 Intermediate Similarity NPC283041
0.8452 Intermediate Similarity NPC215921
0.8452 Intermediate Similarity NPC70016
0.8447 Intermediate Similarity NPC478026
0.8443 Intermediate Similarity NPC208069
0.8442 Intermediate Similarity NPC478219
0.8438 Intermediate Similarity NPC97637
0.8438 Intermediate Similarity NPC187934
0.8435 Intermediate Similarity NPC315275
0.8431 Intermediate Similarity NPC476821
0.8431 Intermediate Similarity NPC119767
0.8431 Intermediate Similarity NPC81835
0.8424 Intermediate Similarity NPC470583
0.8424 Intermediate Similarity NPC19056
0.8421 Intermediate Similarity NPC474309
0.8418 Intermediate Similarity NPC246466
0.8418 Intermediate Similarity NPC478226
0.8411 Intermediate Similarity NPC127857
0.8411 Intermediate Similarity NPC474692
0.8408 Intermediate Similarity NPC478133
0.8408 Intermediate Similarity NPC99381
0.8405 Intermediate Similarity NPC175477
0.84 Intermediate Similarity NPC130485
0.8397 Intermediate Similarity NPC295646
0.8395 Intermediate Similarity NPC20237
0.8392 Intermediate Similarity NPC247250
0.8392 Intermediate Similarity NPC767
0.8387 Intermediate Similarity NPC164762
0.8378 Intermediate Similarity NPC261292
0.8378 Intermediate Similarity NPC301915
0.8375 Intermediate Similarity NPC117985
0.8375 Intermediate Similarity NPC317544
0.8375 Intermediate Similarity NPC316457
0.8373 Intermediate Similarity NPC176246
0.8367 Intermediate Similarity NPC142027
0.8366 Intermediate Similarity NPC147250
0.8366 Intermediate Similarity NPC51513
0.8366 Intermediate Similarity NPC473023
0.8366 Intermediate Similarity NPC202112
0.8364 Intermediate Similarity NPC65118
0.8356 Intermediate Similarity NPC171968
0.8355 Intermediate Similarity NPC274085
0.8355 Intermediate Similarity NPC89664
0.8355 Intermediate Similarity NPC42540
0.8355 Intermediate Similarity NPC244691
0.8355 Intermediate Similarity NPC471906
0.8355 Intermediate Similarity NPC151607
0.8354 Intermediate Similarity NPC478223
0.8344 Intermediate Similarity NPC155686
0.8344 Intermediate Similarity NPC308572
0.8344 Intermediate Similarity NPC471695
0.8344 Intermediate Similarity NPC107009
0.8343 Intermediate Similarity NPC209865
0.8333 Intermediate Similarity NPC262819
0.8333 Intermediate Similarity NPC3218
0.8333 Intermediate Similarity NPC178281
0.8333 Intermediate Similarity NPC91809
0.8333 Intermediate Similarity NPC227485
0.8323 Intermediate Similarity NPC470581
0.8323 Intermediate Similarity NPC83331
0.8323 Intermediate Similarity NPC470582
0.8323 Intermediate Similarity NPC84142
0.8323 Intermediate Similarity NPC115447
0.8323 Intermediate Similarity NPC266513
0.8322 Intermediate Similarity NPC221104
0.8322 Intermediate Similarity NPC9121
0.8322 Intermediate Similarity NPC177307
0.8313 Intermediate Similarity NPC294149
0.8313 Intermediate Similarity NPC284495
0.8312 Intermediate Similarity NPC112216
0.8312 Intermediate Similarity NPC161239
0.8312 Intermediate Similarity NPC165260
0.8312 Intermediate Similarity NPC198455
0.8312 Intermediate Similarity NPC476463
0.8312 Intermediate Similarity NPC5568
0.8311 Intermediate Similarity NPC291454
0.8303 Intermediate Similarity NPC472620
0.8301 Intermediate Similarity NPC83272
0.8301 Intermediate Similarity NPC475923

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC44378 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8333 Intermediate Similarity NPD8150 Discontinued
0.8246 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD7075 Discontinued
0.8098 Intermediate Similarity NPD6232 Discontinued
0.8061 Intermediate Similarity NPD7473 Discontinued
0.8056 Intermediate Similarity NPD1470 Approved
0.8 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7819 Suspended
0.7987 Intermediate Similarity NPD6190 Approved
0.7975 Intermediate Similarity NPD3226 Approved
0.7947 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7925 Intermediate Similarity NPD4380 Phase 2
0.7888 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7841 Intermediate Similarity NPD6534 Approved
0.7841 Intermediate Similarity NPD6535 Approved
0.784 Intermediate Similarity NPD3817 Phase 2
0.7829 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD6801 Discontinued
0.7826 Intermediate Similarity NPD1934 Approved
0.7821 Intermediate Similarity NPD3300 Phase 2
0.7803 Intermediate Similarity NPD8434 Phase 2
0.7791 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.779 Intermediate Similarity NPD7435 Discontinued
0.7784 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD6166 Phase 2
0.7778 Intermediate Similarity NPD5408 Approved
0.7778 Intermediate Similarity NPD1201 Approved
0.7778 Intermediate Similarity NPD5404 Approved
0.7778 Intermediate Similarity NPD5406 Approved
0.7778 Intermediate Similarity NPD5405 Approved
0.7747 Intermediate Similarity NPD8320 Phase 1
0.7747 Intermediate Similarity NPD8319 Approved
0.7746 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD8312 Approved
0.7733 Intermediate Similarity NPD8313 Approved
0.773 Intermediate Similarity NPD5402 Approved
0.7727 Intermediate Similarity NPD2346 Discontinued
0.7722 Intermediate Similarity NPD2534 Approved
0.7722 Intermediate Similarity NPD6781 Approved
0.7722 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD6780 Approved
0.7722 Intermediate Similarity NPD2532 Approved
0.7722 Intermediate Similarity NPD6779 Approved
0.7722 Intermediate Similarity NPD6782 Approved
0.7722 Intermediate Similarity NPD2533 Approved
0.7722 Intermediate Similarity NPD6778 Approved
0.7722 Intermediate Similarity NPD6776 Approved
0.7722 Intermediate Similarity NPD6777 Approved
0.7714 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7709 Intermediate Similarity NPD7700 Phase 2
0.7709 Intermediate Similarity NPD7699 Phase 2
0.7702 Intermediate Similarity NPD6599 Discontinued
0.7683 Intermediate Similarity NPD3882 Suspended
0.7682 Intermediate Similarity NPD943 Approved
0.7674 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD6799 Approved
0.7658 Intermediate Similarity NPD7390 Discontinued
0.7647 Intermediate Similarity NPD5844 Phase 1
0.7636 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD6959 Discontinued
0.7588 Intermediate Similarity NPD3751 Discontinued
0.7588 Intermediate Similarity NPD3818 Discontinued
0.758 Intermediate Similarity NPD4628 Phase 3
0.7564 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD2801 Approved
0.7558 Intermediate Similarity NPD6797 Phase 2
0.7558 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD3764 Approved
0.7548 Intermediate Similarity NPD2935 Discontinued
0.7546 Intermediate Similarity NPD7411 Suspended
0.7544 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD7874 Approved
0.7516 Intermediate Similarity NPD5403 Approved
0.7516 Intermediate Similarity NPD230 Phase 1
0.7514 Intermediate Similarity NPD7251 Discontinued
0.7514 Intermediate Similarity NPD6559 Discontinued
0.75 Intermediate Similarity NPD7697 Approved
0.75 Intermediate Similarity NPD7698 Approved
0.75 Intermediate Similarity NPD7074 Phase 3
0.75 Intermediate Similarity NPD7696 Phase 3
0.7483 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD7808 Phase 3
0.7459 Intermediate Similarity NPD7870 Phase 2
0.7459 Intermediate Similarity NPD7871 Phase 2
0.7455 Intermediate Similarity NPD1465 Phase 2
0.7453 Intermediate Similarity NPD1512 Approved
0.7452 Intermediate Similarity NPD1549 Phase 2
0.7442 Intermediate Similarity NPD7054 Approved
0.744 Intermediate Similarity NPD5494 Approved
0.7433 Intermediate Similarity NPD7701 Phase 2
0.7425 Intermediate Similarity NPD3749 Approved
0.741 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD7472 Approved
0.7391 Intermediate Similarity NPD5401 Approved
0.7389 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD6212 Phase 3
0.7389 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD6213 Phase 3
0.7389 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD1510 Phase 2
0.7371 Intermediate Similarity NPD4954 Approved
0.7371 Intermediate Similarity NPD4955 Approved
0.7371 Intermediate Similarity NPD5026 Approved
0.7371 Intermediate Similarity NPD5034 Approved
0.7371 Intermediate Similarity NPD5028 Approved
0.7371 Intermediate Similarity NPD36 Approved
0.7368 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD8166 Discontinued
0.7353 Intermediate Similarity NPD3787 Discontinued
0.7329 Intermediate Similarity NPD1511 Approved
0.7326 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7316 Intermediate Similarity NPD7801 Approved
0.7314 Intermediate Similarity NPD5030 Phase 2
0.7303 Intermediate Similarity NPD5037 Approved
0.7303 Intermediate Similarity NPD5038 Approved
0.7302 Intermediate Similarity NPD8151 Discontinued
0.7284 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7266 Discontinued
0.7278 Intermediate Similarity NPD6234 Discontinued
0.7261 Intermediate Similarity NPD2799 Discontinued
0.726 Intermediate Similarity NPD9545 Approved
0.7251 Intermediate Similarity NPD5711 Approved
0.7251 Intermediate Similarity NPD5710 Approved
0.725 Intermediate Similarity NPD3750 Approved
0.725 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7247 Intermediate Similarity NPD5036 Approved
0.7244 Intermediate Similarity NPD1607 Approved
0.7226 Intermediate Similarity NPD1240 Approved
0.7226 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD1164 Approved
0.7216 Intermediate Similarity NPD8368 Discontinued
0.7216 Intermediate Similarity NPD7685 Pre-registration
0.7215 Intermediate Similarity NPD2796 Approved
0.7212 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD2313 Discontinued
0.7186 Intermediate Similarity NPD37 Approved
0.7179 Intermediate Similarity NPD447 Suspended
0.7176 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7166 Intermediate Similarity NPD6823 Phase 2
0.7161 Intermediate Similarity NPD6663 Approved
0.716 Intermediate Similarity NPD7768 Phase 2
0.716 Intermediate Similarity NPD4966 Approved
0.716 Intermediate Similarity NPD7236 Approved
0.716 Intermediate Similarity NPD4967 Phase 2
0.716 Intermediate Similarity NPD4965 Approved
0.7157 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD5035 Approved
0.7133 Intermediate Similarity NPD9269 Phase 2
0.7124 Intermediate Similarity NPD5736 Approved
0.7123 Intermediate Similarity NPD9493 Approved
0.7119 Intermediate Similarity NPD5029 Approved
0.7119 Intermediate Similarity NPD5031 Approved
0.7119 Intermediate Similarity NPD5027 Approved
0.7115 Intermediate Similarity NPD4060 Phase 1
0.711 Intermediate Similarity NPD3926 Phase 2
0.7108 Intermediate Similarity NPD7458 Discontinued
0.7107 Intermediate Similarity NPD1551 Phase 2
0.7095 Intermediate Similarity NPD8407 Phase 2
0.7086 Intermediate Similarity NPD7228 Approved
0.7086 Intermediate Similarity NPD7799 Discontinued
0.7076 Intermediate Similarity NPD919 Approved
0.7073 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD1471 Phase 3
0.7063 Intermediate Similarity NPD2344 Approved
0.7062 Intermediate Similarity NPD5953 Discontinued
0.7048 Intermediate Similarity NPD7239 Suspended
0.7047 Intermediate Similarity NPD7783 Phase 2
0.7047 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD7033 Discontinued
0.7033 Intermediate Similarity NPD8360 Approved
0.7033 Intermediate Similarity NPD8361 Approved
0.7012 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD8285 Discontinued
0.7 Intermediate Similarity NPD6099 Approved
0.7 Intermediate Similarity NPD6100 Approved
0.6988 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6987 Remote Similarity NPD6798 Discontinued
0.6986 Remote Similarity NPD2629 Approved
0.698 Remote Similarity NPD9268 Approved
0.6968 Remote Similarity NPD6832 Phase 2
0.6962 Remote Similarity NPD6355 Discontinued
0.6957 Remote Similarity NPD5763 Approved
0.6957 Remote Similarity NPD5762 Approved
0.6948 Remote Similarity NPD2798 Approved
0.6948 Remote Similarity NPD6007 Clinical (unspecified phase)
0.694 Remote Similarity NPD8435 Approved
0.6937 Remote Similarity NPD3748 Approved
0.6933 Remote Similarity NPD2932 Approved
0.6933 Remote Similarity NPD3019 Approved
0.6933 Remote Similarity NPD7003 Approved
0.6928 Remote Similarity NPD6273 Approved
0.6923 Remote Similarity NPD9266 Approved
0.6923 Remote Similarity NPD74 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data